CD8A and neoplasm: Consistent with our CITE-seq analysis, the number of CD8+ TexTerm cells—as determined by reduced TOX and inhibitory receptor (PD1+TOX+) expression—decreased significantly in tumours from DR-conditioned animals compared to AL-fed mice 14 days post tumour implantation (Fig. 3f).